Tim Bringman

Title: Tim Bringman: Innovator in Pharmaceutical Compositions

Introduction

Tim Bringman is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune conditions. With a total of 6 patents to his name, Bringman has focused on innovative drug delivery systems and immune response modulation.

Latest Patents

Among his latest patents, Bringman has developed compositions that utilize HL-60-related lectins for drug delivery and the detection of lectin-expressing cells. These pharmaceutical compositions are designed to treat autoimmune conditions such as rheumatoid arthritis, myasthenia gravis, and multiple sclerosis. The active ingredient in these compositions is a soluble lectin with a molecular weight of approximately 14 kilodaltons. This lectin binds to β-galactoside-containing moieties, stimulating hemagglutination in standard assays. The compositions can also be combined with general immunosuppressants to enhance their effectiveness.

Career Highlights

Tim Bringman has worked with Incyte Pharmaceuticals, Inc., where he has contributed to the development of innovative pharmaceutical solutions. His work has focused on creating compositions that can effectively modulate the immune response, particularly in the context of allergic reactions and organ transplant rejection.

Collaborations

Throughout his career, Bringman has collaborated with notable professionals in the field, including Glenn E. Nedwin and Pierre-Olivier Couraud. These collaborations have further enriched his research and development efforts.

Conclusion

Tim Bringman is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of autoimmune diseases. His innovative approaches and collaborations highlight his commitment to advancing medical science.